For developers working with databases, having the right tools can make or break a project. IntelliJ IDEA database tools stand ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Real-time data improves visibility and speeds up issue detection, reducing downtime and delays. Live metrics enable faster, more effective production decisions and help optimize performance on the ...

Architecture has always depended on systems of representation to make ideas visible before they exist. But where Filippo Brunelleschi's fifteenth-century linear perspective once organized space ...

Architectural visualization has long played a key role in communicating and shaping design ideas. Today, that role is expanding. With the rise of artificial intelligence, visualization is becoming ...

Visualization can be an athlete’s secret weapon, and it’s a skill that you can practice in the car, at home, or whenever you have downtime in your sport. Using mental imagery to work through key ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...

Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...

Anthropic’s Claude Cowork now features Live Artifacts, a capability designed to create real-time dashboards that automatically update with data from connected applications. Unlike static dashboards ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.